Tech Company Financing Transactions
Forty Seven Funding Round
Forty Seven, operating out of Menlo Park, raised $6 million from The Leukemia & Lymphoma Society.
Transaction Overview
Company Name
Announced On
8/7/2019
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
The Leukemia & Lymphoma Society (Lee Greenberger)
Proceeds Purpose
Forty Seven will use LLS TAP funding and leverage LLS value-added resources for 5F9 in MDS.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1490 O'Brien Dr. A
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
With a passion for pioneering breakthrough solutions, Forty Seven Inc. is committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark McCamish
Chief Financial Officer
Ann Rhoads
Chief Medical Officer
Chris Takimoto
Founder
Mark Chao
VP - Bus. Development
Craig Gibbs
VP - Manufacturing
Qinghai Zhao
VP - Operations
Kyle Elrod
VP - R & D
Jens-Peter Volkmer
Browse more venture capital transactions:
Prev: 8/7/2019: Remarkably venture capital transaction
Next: 8/7/2019: Zero Fasting venture capital transaction
Share this article
News on VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs